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ABSTRACT
CONTEXT AND OBJECTIVE: Healthcare decision-making is complex and should involve healthcare pro-
fessionals, patients and the best level of evidence. The speed of information production creates barriers 
against keeping up to date. In this light, methodologists have proposed a new type of study: overviews of 
systematic reviews (OoRs). The aim here was to introduce and demonstrate the role of OoRs in information 
synthesis for healthcare professionals, managers, researchers and patients. 
DESIGN AND SETTING: Time-series study conducted at the Brazilian Cochrane Center, jointly with the 
Postgraduate Program on Internal Medicine and Therapeutics, Discipline of Emergency Medicine and 
Evidence-Based Medicine, Department of Medicine, Federal University of São Paulo.
METHODS: To show the growth in the numbers of published papers that provide high-level evidence 
and thus demonstrate the importance of OoRs for synthesis and integration of information, three filters 
for study designs were applied to two databases. An equation for predicting the expected number of 
published papers was developed and applied. 
RESULTS: Over the present decade, the number of randomized controlled trials in Medline might reach 
2,863,203 and the number of systematic reviews might reach 174,262. Nine OoRs and 15 OoRs protocols 
have been published in the Cochrane Library. 
CONCLUSIONS: With the exponential growth of published papers, as shown in this study, a new type of 
study directed especially towards healthcare decision-makers was proposed, named “overview of system-
atic reviews”. This could reduce the uncertainties in decision-making and generate a new hierarchy in the 
pyramid of evidence. 
RESUMO
CONTEXTO E OBJETIVO: A tomada de decisão em saúde é complexa e deve envolver o profissional de 
saúde, o paciente e a evidência de melhor nível. A velocidade de geração da informação cria barreiras para 
manter-se atualizado. Diante disso, metodologistas propuseram um novo tipo de estudo, as overviews de 
revisões sistemáticas (OoRs). O objetivo é introduzir e demonstrar o papel das OoRs na síntese de informa-
ções para profissionais da área da saúde, gestores, pesquisadores e pacientes.
TIPO DE ESTUDO E LOCAL: Estudo de série temporal realizado no Centro Cochrane do Brasil, em 
conjunto com o Programa de Pós-Graduação em Medicina Interna e Terapêutica da Disciplina de 
Medicina de Urgência e Medicina Baseada em Evidências do Departamento de Medicina da Univer-
sidade Federal de São Paulo.
MÉTODOS: Para mostrar o crescimento das publicações que fornecem evidência com alto nível e assim 
justificar a importância das OoRs na síntese e integração das informações, três filtros para desenhos de 
estudos foram aplicados em duas bases de dados. Uma equação de predição do número esperado 
de publicações foi desenvolvida e aplicada.
RESULTADOS: Na presente década, o número de ensaios clínicos randomizados no Medline poderá che-
gar a 2.863.203 e o número de revisões sistemáticas poderá chegar a 174.262. Nove OoRs e 15 protocolos 
de OoRs foram publicados na Biblioteca Cochrane.
CONCLUSÕES: Com o crescimento exponencial das publicações, demonstrado neste estudo, um novo 
tipo de estudo, direcionado especialmente aos decisores em saúde, foi proposto, a OoRs, o qual poderá 
reduzir incertezas para a tomada de decisão e gerar uma nova hierarquia na pirâmide de evidências.
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INTRODUCTION
The effectiveness of healthcare clinical practice depends on evi-
dence based on higher quality, and practices to be implemented 
should be discussed between healthcare professionals and their 
patients, for decision-making.1-3 In order to make this process 
work, healthcare professionals need to keep up to date. However, 
this is a complex challenge, given the globalized world and the 
speed at which information is disseminated.
One example of the complexity of keeping up to date was 
given by Davidoff et al.4 In 1992, it was estimated that health-
care professionals should read 17 to 20 original papers every day 
to keep up to date in their field. In Medline,5 the world’s largest 
medical library, more than 736,000 new records were published 
in 2011, with over 21 million citations in PubMed.
An alternative way to reduce the complexity of keeping up 
to date and facilitate clinical decision-making is to use system-
atic reviews (SRs). One of the primary functions of this type of 
study is to summarize clinical information from several studies 
in order to answer a question relating to diagnosis, prevention 
or treatment in areas in which the results may or may not be in 
agreement, through critical evaluation of the evidence.6,7
Taking into consideration only the most important database 
of SRs, i.e. the Cochrane Library, more than 7,000 articles have 
been published.8 Given this large amount of information, pro-
fessional updating remains a challenge, even when resorting to 
SRs. One possible solution to the problem has been put forward 
by methodologists who are experts on SRs: a new type of study 
called an overview of systematic reviews (OoRs), considered to 
be a “friendly front end” for healthcare decision-making.9-11 By 
definition, an OoRs is a study designed to integrate and pro-
duce a synthesis of information from existing SRs on a particular 
clinical condition, considering all the available interventions for 
treating or preventing this condition.9-11
For didactic purposes, the present analysis will be published 
as a series of three articles. Part I, presented here, focuses on the 
growth of published papers presenting the best level of evidence 
for decision-making relating to healthcare, thereby justifying the 
creation of OoRs. Part II, to be presented in a forthcoming arti-
cle, will describe the state of the art of OoRs from the Cochrane 
Collaboration. In Part III, a new hierarchical evidence pyramid 
will be proposed, taking this new type of study into consideration.
OBJECTIVE
The objective of this study was to introduce and demonstrate the 
role of OoRs in relation to synthesis of information for healthcare 
professionals, managers, researchers and patients.
METHODS
This was a time-series study that included application of filters to 
study designs (to select studies that provide the highest level of 
evidence) in virtual databases, in order to show the growing num-
ber of published papers within the field of healthcare that pro-
vide high levels of evidence for decision-making and thus seek to 
demonstrate the importance of OoRs as a type of study that pro-
vides a synthesis of the evidence and integrates it. For this, two 
databases were selected (the Cochrane Library via the Cochrane 
Database of Systematic Reviews, and Medline via PubMed) and 
three search filters for study designs were applied. The first fil-
ter used (filter A) was the sensitivity-maximizing version of the 
Cochrane Highly Sensitive Search Strategy12 for identifying ran-
domized controlled trials (RCTs) in Medline. The second filter 
(filter B) was designed to search for all systematic reviews (SRs) 
in Medline.13,14 The third search filter (filter C) was developed to 
identify overviews of systematic reviews (OoRs) in the Cochrane 
Library. The three search filters used are shown in Chart 1.
Subsequently, an equation to predict expected future num-
bers of published papers was modeled (designed). This equation 
was based on the fraction of the present decade that has already 
elapsed, in order to determine the cumulative frequency for the 
period. The equation thus developed is shown in Figure 1.
RESULTS
Up to the cutoff date of May 21, 2012, more than two million RCTs 
(n = 2,336,617) were identified by applying filter A (Figure  2, 
part “a”, in dark gray). The forecast growth was taken to be based 
on the number of studies published over the date range of the 
search. Thus, over the decade between 2010 and 2020, the num-
ber of RCTs in Medline might reach 2,863,203 (Figure 2, part “a”, 
in light gray). 263,002 RCTs were published in the decade begin-
ning in 2010, up to the cutoff date considered, but more than 
526,586 RCTs are expected over the remainder of the decade, 
thus resulting in almost 800,000 new RCTs published in Medline 
over the entire decade 2010-2020.
Up to the cutoff date of June 6, 2012, more than 100,000 SRs 
(n = 127,044) were identified by applying filter B to the Medline 
database (Figure 2, part “b”, in dark gray). The forecast growth 
was taken to be based on the number of studies published over 
the date range of the search. Thus, over the decade between 2010 
and 2020, the number of SRs in Medline might reach 174,262 
(Figure 2, part “b”, in light gray). 37,785 SRs were published in 
the decade beginning in 2010, up to the cutoff date considered, 
but more than 47,281 SRs are expected over the remainder of the 
decade, thus resulting in more than 85,000 new SRs published in 
Medline over the entire decade 2010-2020.
By applying filter C, to identify OoRs in the Cochrane 
Library, 57 studies were identified, but 33 were excluded 
because they were not OoRs (using a very sensitive but low-
specificity search). Thus, up to the cutoff date of June 15, 2012, 
nine OoRs had been published, and 15 OoRs protocols were in 
this database (Table 1).15-38
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DISCUSSION
The information from Medline, which is the world’s largest medi-
cal library,5 with citations in its database going back to the 1940s, 
shows that PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) 
includes over 21 million citations for biomedical literature, com-
prising journals and books on the life sciences that are online 
through Medline. In 2011 alone, over 736,000 new references 
were published and, therefore, to acknowledge all of these new 
papers would have meant reading about 84 articles per day.
In this study, we chose to analyze the growth in the numbers 
of published RCTs, SRs and OoRs, because these study designs 
present the highest levels in the hierarchy of evidence for clinical 
decision-making.39
Medline was chosen as the database to assess because it is 
considered to be the most important search tool within the field 
of healthcare.5 The Cochrane Library was chosen because it is the 
largest and most important database of SRs and OoRs with over 
7,000 citations.7
An evidence-level hierarchy was previously proposed in 
order to provide the best evidence for decision-making in health-
care.39 However, this was a heuristic solution, i.e. it assumed a 
solution that was close to the ideal, even though such a solution 
would not necessarily be the best possible solution. Nonetheless, 
it may be considered satisfactory. In order to achieve a satisfac-
tory hierarchy for evidence levels, the quality of evidence is cru-
cial and should be evaluated.
The quality of published papers may be compromised 
for a variety of reasons, which may include methodological 
faults, conflicts of interest, data manipulation and so on. Thus, 
healthcare professionals not only need to keep up to date but 
also  should know how to judge the quality of evidence. To do 
this, certain  tools are recommended, such as the Cochrane 
Collaboration’s tool40 for assessing RCT risk of bias and the 
AMSTAR tool for assessing the methodological quality of SRs.41 
To reduce the uncertainties in healthcare decision-making, 
all the relevant studies need to be found. Therefore, the search 
strategy should be highly sensitized, i.e. it should be able to detect 
Mesh terms (Medical Subject Headings) and free-text terms 
within titles and abstracts indexed in the databases considered.11 
This implies that not all RCTs and SRs counted in Figure 2 are 
actually the types of studies for which the search strategy was 
developed. This is a possible limitation of the present analysis.
Another point to be noted is in relation to the predicted 
growth among the types of studies considered in the present 
analysis. These numbers represent numerical approximations 
based on the publication behavior of previous decades.
A. Filter for randomized controlled trials (Medline via PubMed)
((randomized controlled trial [pt]) OR (controlled clinical trial [pt]) OR (randomized [tiab]) OR (placebo [tiab]) OR (drug therapy [sh]) OR (randomly 
[tiab]) OR (trial [tiab]) OR (groups [tiab])) AND (humans [mh])
B. Filter for systematic reviews (Medline via PubMed)
(((((((systematic review[ti] OR meta-analysis[pt] OR meta-analysis[ti] OR systematic literature review[ti] OR (systematic review[tiab] AND review[pt]) 
OR consensus development conference[pt] OR practice guideline[pt] OR cochrane database syst rev[ta] OR acp journal club[ta] OR health technol 
assess[ta] OR evid rep technol assess summ[ta])) OR (evidence based[ti] OR evidence-based medicine[mh] OR best practice*[ti] OR evidence 
synthesis[tiab])) AND (review[pt] OR diseases category[mh] OR behavior and behavior mechanisms[mh] OR therapeutics[mh] OR evaluation studies[pt] 
OR validation studies[pt] OR guideline[pt])) OR (systematic[tw] OR systematically[tw] OR critical[tiab] OR (study selection[tw]) OR (predetermined[tw] 
OR inclusion[tw] AND criteri*[tw]) OR exclusion criteri*[tw] OR main outcome measures[tw] OR standard of care[tw] OR standards of care[tw])) 
AND (survey[tiab] OR surveys[tiab] OR overview*[tw] OR review[tiab] OR reviews[tiab] OR search*[tw] OR handsearch[tw] OR analysis[tiab] OR 
critique[tiab] OR appraisal[tw] OR (reduction[tw] AND (risk[mh] OR risk[tw]) AND (death OR recurrence)))) AND (literature[tiab] OR articles[tiab] OR 
publications[tiab] OR publication[tiab] OR bibliography[tiab] OR bibliographies[tiab] OR published[tiab] OR unpublished[tw] OR citation[tw] OR 
citations[tw] OR database[tiab] OR internet[tiab] OR textbooks[tiab] OR references[tw] OR scales[tw] OR papers[tw] OR datasets[tw] OR trials[tiab] OR 
meta-analy*[tw] OR (clinical[tiab] AND studies[tiab]) OR treatment outcome[mh] OR treatment outcome[tw])) NOT (letter[pt] OR newspaper article[pt] 
OR comment[pt])
C. Filter for overviews of systematic reviews (The Cochrane Library, via Cochrane Database of Systematic Reviews)
(overview):ti or (overview):ab or (overview):kw in Cochrane Reviews
Chart 1. Search filter from study designs used
Figure 1. Equation for predicting the expected number of published 
papers.
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Year considered OoRs protocol % (n)references
OoRs
% (n)references
Both
% (n)
2009 4.2 (1)15 4.2 (1)30 8.3 (2)
2010 12.5 (3)16-18 4.2 (1)31 16.7 (4)
2011 33.3 (8)19-26 20.8 (5)32-36 54.2 (13)
2012 12.5 (3)27-29 8.3 (2)37,38 20.8 (5)
2009 to 2012 62.5 (15)15-29 37.5 (9)30-38 100 (24)
Table 1. Growth of overviews of systematic reviews (OoRs) in the Cochrane Library
Part “a” of the figure represents the number and growth rate (%) of randomized controlled trials (RCTs) per decade, published in Medline. Part 
“b” of the figure represents the number and growth rate (%) of systematic reviews (SRs) per decade, published in Medline. The dark gray regions 
represent the observed values up to 2012; the light gray region represents the prediction for the remainder of the decade 2010 |– 2020.
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Figure 2. Growth in the numbers of published papers in Medline with a high level of evidence for healthcare decision-making.
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Ecological evidence can be highlighted to explain the ascen-
dency of RCT and SR publication: 1) the vertex of the growth 
curve of the cumulative number of RCTs occurs between 1970 
and 1980 (Figure 2, part “a”), which coincides with historical 
events (for example, Archibald Cochrane’s warning about pro-
fessionals’ collective ignorance about healthcare and the first 
register of RCTs, among others); 2) the vertex of the growth 
curve of the cumulative number of SRs occurs close to the 
1990s (Figure 2, part “b”), which coincides with the birth of the 
Cochrane Collaboration,42 which holds a permanent seat within 
the World Health Organization, as well as being one of the most 
important producers of this type of study. Although there is a 
risk of ecological fallacy in this interpretation, the hypotheses 
presented show validity of logic.
Despite the limitations noted, the growth in RCTs and SRs 
has, as seen from the results, been exponential. Because health-
care decision-making is naturally complex, SR methodologists 
have proposed the use of overviews of systematic reviews,8-10 
which have also shown growth in the number of published 
papers.
In Part II of this series of three papers, the state of art of over-
views of systematic reviews and details of study design will be 
presented.
CONCLUSIONS
Keeping up to date remains a challenge, considering the great 
quantity and varying quality of information available. Thus, SR 
methodologists have proposed a new type of study especially 
suited for healthcare decision-makers, named “overview of sys-
tematic reviews”. This new type of study was developed to provide 
a synthesis and integrate information from multiple studies in 
order to reduce the uncertainties in decision-making. This may 
generate a new hierarchy in the pyramid of evidence.
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